Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Cash Flows Used in Operating Activities:
Net loss	$ (1,804)	$ (74)	$ (3,739)	$ (428)	$ (1,779)	$ (4,682)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount and fees					1,265	230
Accrued interest expense					989	749
Derivative income (expense)					(1,425)	3,055
(Gain) Loss on debt extinguishment	(92)		177		(307)	177
Changes in operating assets and liabilities:
Prepaid expenses					(3)
Accounts payable					(38)	30
Accrued expenses					36	72
Net Cash Used in Operating Activities					(1,262)	(369)
Cash Flows Provided by Financing Activities:
Proceeds from notes payable and convertible notes, net of original issue discounts					2,200	591
Notes payable and convertible notes issuance costs					(328)	(72)
Repurchase of common stock					(2)
Repayment of principal and interest on notes payable					(551)
Net Cash Provided by Financing Activities					1,319	519
Net increase in cash					57	150
Cash – Beginning of Period		$ 76		$ 1	76	1	$ 1
Cash - End of Period	$ 133		1,514		133	1,514	$ 76
Supplementary Cash Flow Information:
Cash paid for interest					94
Cash paid for taxes
Non-cash Investing and Financing Activities:
Conversion of Series E Preferred stock to common stock					5,056	4
Conversion of Series F Preferred stock to common stock					541
Debt discounts for issuance costs, warrants and derivatives					10
Issuance of common stock for conversion of convertible notes					28	111
Issuance of common stock and warrants with convertible notes					20	473
Cashless exercise of warrants						4
Accrued and deemed dividends					$ 574	$ 1,679